Heart Disease: Genetic Risks & New Insights into Prevention

For decades, coronary artery disease was explained by a seemingly simple equation: high cholesterol, hypertension, smoking, and a sedentary lifestyle. That understanding led to decisive advances in prevention and treatment, but left an open question: why do people with similar habits develop vastly different outcomes?

Science is beginning to answer this with clarity: the heart also follows instructions written in our DNA.

Recent research, highlighted by cardiologist Eric Topol and October 30, 2025, published in The New England Journal of Medicine, synthesizes one of the most profound conceptual shifts in modern cardiology. Coronary artery disease has a solid, measurable genetic basis.

It’s not just about rare mutations that elevate cholesterol to extreme levels, but the silent accumulation of hundreds of common genetic variants that, combined, tip the scales of risk throughout life.

This new approach redefines how we understand atherosclerosis, the process by which plaques form in the arteries supplying the heart, potentially leading to heart attack or stroke. Genetics is no longer a marginal factor; it becomes a structural one, interacting with environment, diet, exercise, and medical treatments from early stages.

“The monogenic causes of coronary artery disease, such as certain hereditary forms of hypercholesterolemia, affect approximately one in 250 people,” explained one of the study authors, Dr. Heribert Schunkert, a cardiologist and director of the Department of Cardiology at the German Heart Center Munich. “In these cases, a single mutation drastically alters lipid metabolism and elevates cardiovascular risk from a young age. These cases explain part of the problem, but not the majority of events that occur at a population level.”

The emerging picture isn’t limited to single gene defects. Researchers are increasingly focused on common genetic variants, each with a small effect, but capable of a considerable impact when they accumulate. These variants are widely distributed in the population and don’t produce obvious symptoms on their own. However, their combination can increase the risk of coronary artery disease three to five times compared to the average.

Researchers have developed what are called polygenic risk scores. These tools integrate hundreds of genetic variants into a single indicator reflecting a person’s relative inherited risk. In the top five percent of these scores, cardiovascular risk soars even without traditional clinical factors.

Importantly, these scores don’t replace classic clinical models, but complement them. Genetic risk can multiply the absolute risk calculated from age, blood pressure, or cholesterol levels, allowing for more precise and personalized risk stratification.

“Polygenic risk scores for heart disease, incorporating hundreds of common genomic variants, are capable of identifying risks for patients far beyond traditional risk factors, and the benefit of getting ahead of the disease—that is, prevention,” Topol noted on X.

Further research has revealed that more than 30 percent of heart disease risk comes from genetic factors, a figure significantly higher than previously estimated. This research didn’t focus solely on isolated genes, but on gene regulatory networks (GRNs). These networks group genes that interact to control specific cellular functions. Their coordinated behavior decisively influences processes like inflammation, lipid metabolism, and vascular response.

Researchers analyzing vascular and metabolic tissues from individuals with coronary artery disease identified 28 independent regulatory networks whose genetic variation explained an additional 11 percent of the inherited risk. This finding raised the total estimated heritability of coronary artery disease to approximately 32 percent.

“The results of this study demonstrate that the risk of heart disease is a concerted outcome of interactions between genetic variants and biological environments,” explained Johan LM Björkegren, a professor of Cardiology and Genetics at the Icahn School of Medicine at Mount Sinai. This approach creates a framework for identifying new risk genes in key tissues and improving clinical prediction and intervention.

“A mystery of recent investigations was the fact that many genes that contribute to the genetics of coronary artery disease affect mechanisms that were not expected ” said co-author Dr. Pradeep Natarajan. The work helped to understand how those genes work together to precipitate or prevent the disease.

This shift in perspective has profound implications. It’s no longer just about searching for a single guilty gene, but mapping complete systems that regulate cardiovascular biology. In that map, small variations can be amplified or attenuated depending on each individual’s metabolic, inflammatory, and environmental context.

In the long term, this knowledge opens the door to more refined prevention strategies. Identifying high-risk individuals genetically from a young age could allow for intervention before irreversible damage occurs in the arteries. It also drives the development of therapies targeted at specific nodes within these networks, with greater efficacy and fewer side effects.

Coronary artery disease remains a leading cause of death worldwide, but its understanding is entering a new phase. The heart is no longer studied solely as a pump subject to the wear and tear of time and habits, but as the dynamic result of a complex genetic inheritance interacting with the environment throughout life. In that intersection of genes and biology, cardiology is beginning to write its next chapter.